Abstract
Summary
The d-isomer of the codeine analog of levorphanol. Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (receptors, N-methyl-D-aspartate) and acts as a non-competitive channel blocker. It is one of the widely used antitussives, and is also used to study the involvement of glutamate receptors in neurotoxicity.
LPI (LP Information)' newest research report, the “Dextromethorphan Industry Forecast” looks at past sales and reviews total world Dextromethorphan sales in 2022, providing a comprehensive analysis by region and market sector of projected Dextromethorphan sales for 2023 through 2029. With Dextromethorphan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dextromethorphan industry.
This Insight Report provides a comprehensive analysis of the global Dextromethorphan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dextromethorphan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dextromethorphan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dextromethorphan and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dextromethorphan.
The global Dextromethorphan market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Dextromethorphan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Dextromethorphan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Dextromethorphan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Dextromethorphan players cover Teva, Sanofi, Johnson & Johnson, Bayer, Bristol-Myers Squibb, GSK, IriSys R&D, TSH Biopharm and Endo International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Dextromethorphan market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Tablets
Syrups
Segmentation by application
Cold
Acute Or Chronic Bronchitis
Bronchial Asthma
Sore Throat
Tuberculosis (TB)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Teva
Sanofi
Johnson & Johnson
Bayer
Bristol-Myers Squibb
GSK
IriSys R&D
TSH Biopharm
Endo International
Axsome Therapeutics
Strive Pharmaceuticals
Cellix Bio
Stada Arzneimittel
Yabo Pharmaceutical
Zhuhai Tianda Pharma
Sichuan Shenghe Pharmaceutical
Zhejiang Kangde Pharmaceutical Group
Zhejiang Anbao Pharmaceutical
Jiangsu Zhongtian Pharmaceutical
LPI (LP Information)' newest research report, the “Dextromethorphan Industry Forecast” looks at past sales and reviews total world Dextromethorphan sales in 2022, providing a comprehensive analysis by region and market sector of projected Dextromethorphan sales for 2023 through 2029. With Dextromethorphan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dextromethorphan industry.
This Insight Report provides a comprehensive analysis of the global Dextromethorphan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dextromethorphan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dextromethorphan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dextromethorphan and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dextromethorphan.
The global Dextromethorphan market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Dextromethorphan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Dextromethorphan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Dextromethorphan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Dextromethorphan players cover Teva, Sanofi, Johnson & Johnson, Bayer, Bristol-Myers Squibb, GSK, IriSys R&D, TSH Biopharm and Endo International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Dextromethorphan market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Tablets
Syrups
Segmentation by application
Cold
Acute Or Chronic Bronchitis
Bronchial Asthma
Sore Throat
Tuberculosis (TB)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Teva
Sanofi
Johnson & Johnson
Bayer
Bristol-Myers Squibb
GSK
IriSys R&D
TSH Biopharm
Endo International
Axsome Therapeutics
Strive Pharmaceuticals
Cellix Bio
Stada Arzneimittel
Yabo Pharmaceutical
Zhuhai Tianda Pharma
Sichuan Shenghe Pharmaceutical
Zhejiang Kangde Pharmaceutical Group
Zhejiang Anbao Pharmaceutical
Jiangsu Zhongtian Pharmaceutical
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dextromethorphan Market Size 2018-2029
2.1.2 Dextromethorphan Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Dextromethorphan Segment by Type
2.2.1 Tablets
2.2.2 Syrups
2.3 Dextromethorphan Market Size by Type
2.3.1 Dextromethorphan Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Dextromethorphan Market Size Market Share by Type (2018-2023)
2.4 Dextromethorphan Segment by Application
2.4.1 Cold
2.4.2 Acute Or Chronic Bronchitis
2.4.3 Bronchial Asthma
2.4.4 Sore Throat
2.4.5 Tuberculosis (TB)
2.5 Dextromethorphan Market Size by Application
2.5.1 Dextromethorphan Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Dextromethorphan Market Size Market Share by Application (2018-2023)
3 Dextromethorphan Market Size by Player
3.1 Dextromethorphan Market Size Market Share by Players
3.1.1 Global Dextromethorphan Revenue by Players (2018-2023)
3.1.2 Global Dextromethorphan Revenue Market Share by Players (2018-2023)
3.2 Global Dextromethorphan Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Dextromethorphan by Regions
4.1 Dextromethorphan Market Size by Regions (2018-2023)
4.2 Americas Dextromethorphan Market Size Growth (2018-2023)
4.3 APAC Dextromethorphan Market Size Growth (2018-2023)
4.4 Europe Dextromethorphan Market Size Growth (2018-2023)
4.5 Middle East & Africa Dextromethorphan Market Size Growth (2018-2023)
5 Americas
5.1 Americas Dextromethorphan Market Size by Country (2018-2023)
5.2 Americas Dextromethorphan Market Size by Type (2018-2023)
5.3 Americas Dextromethorphan Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dextromethorphan Market Size by Region (2018-2023)
6.2 APAC Dextromethorphan Market Size by Type (2018-2023)
6.3 APAC Dextromethorphan Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dextromethorphan by Country (2018-2023)
7.2 Europe Dextromethorphan Market Size by Type (2018-2023)
7.3 Europe Dextromethorphan Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dextromethorphan by Region (2018-2023)
8.2 Middle East & Africa Dextromethorphan Market Size by Type (2018-2023)
8.3 Middle East & Africa Dextromethorphan Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Dextromethorphan Market Forecast
10.1 Global Dextromethorphan Forecast by Regions (2024-2029)
10.1.1 Global Dextromethorphan Forecast by Regions (2024-2029)
10.1.2 Americas Dextromethorphan Forecast
10.1.3 APAC Dextromethorphan Forecast
10.1.4 Europe Dextromethorphan Forecast
10.1.5 Middle East & Africa Dextromethorphan Forecast
10.2 Americas Dextromethorphan Forecast by Country (2024-2029)
10.2.1 United States Dextromethorphan Market Forecast
10.2.2 Canada Dextromethorphan Market Forecast
10.2.3 Mexico Dextromethorphan Market Forecast
10.2.4 Brazil Dextromethorphan Market Forecast
10.3 APAC Dextromethorphan Forecast by Region (2024-2029)
10.3.1 China Dextromethorphan Market Forecast
10.3.2 Japan Dextromethorphan Market Forecast
10.3.3 Korea Dextromethorphan Market Forecast
10.3.4 Southeast Asia Dextromethorphan Market Forecast
10.3.5 India Dextromethorphan Market Forecast
10.3.6 Australia Dextromethorphan Market Forecast
10.4 Europe Dextromethorphan Forecast by Country (2024-2029)
10.4.1 Germany Dextromethorphan Market Forecast
10.4.2 France Dextromethorphan Market Forecast
10.4.3 UK Dextromethorphan Market Forecast
10.4.4 Italy Dextromethorphan Market Forecast
10.4.5 Russia Dextromethorphan Market Forecast
10.5 Middle East & Africa Dextromethorphan Forecast by Region (2024-2029)
10.5.1 Egypt Dextromethorphan Market Forecast
10.5.2 South Africa Dextromethorphan Market Forecast
10.5.3 Israel Dextromethorphan Market Forecast
10.5.4 Turkey Dextromethorphan Market Forecast
10.5.5 GCC Countries Dextromethorphan Market Forecast
10.6 Global Dextromethorphan Forecast by Type (2024-2029)
10.7 Global Dextromethorphan Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Dextromethorphan Product Offered
11.1.3 Teva Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Dextromethorphan Product Offered
11.2.3 Sanofi Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Dextromethorphan Product Offered
11.3.3 Johnson & Johnson Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Dextromethorphan Product Offered
11.4.3 Bayer Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb Dextromethorphan Product Offered
11.5.3 Bristol-Myers Squibb Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bristol-Myers Squibb Main Business Overview
11.5.5 Bristol-Myers Squibb Latest Developments
11.6 GSK
11.6.1 GSK Company Information
11.6.2 GSK Dextromethorphan Product Offered
11.6.3 GSK Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GSK Main Business Overview
11.6.5 GSK Latest Developments
11.7 IriSys R&D
11.7.1 IriSys R&D Company Information
11.7.2 IriSys R&D Dextromethorphan Product Offered
11.7.3 IriSys R&D Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 IriSys R&D Main Business Overview
11.7.5 IriSys R&D Latest Developments
11.8 TSH Biopharm
11.8.1 TSH Biopharm Company Information
11.8.2 TSH Biopharm Dextromethorphan Product Offered
11.8.3 TSH Biopharm Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 TSH Biopharm Main Business Overview
11.8.5 TSH Biopharm Latest Developments
11.9 Endo International
11.9.1 Endo International Company Information
11.9.2 Endo International Dextromethorphan Product Offered
11.9.3 Endo International Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Endo International Main Business Overview
11.9.5 Endo International Latest Developments
11.10 Axsome Therapeutics
11.10.1 Axsome Therapeutics Company Information
11.10.2 Axsome Therapeutics Dextromethorphan Product Offered
11.10.3 Axsome Therapeutics Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Axsome Therapeutics Main Business Overview
11.10.5 Axsome Therapeutics Latest Developments
11.11 Strive Pharmaceuticals
11.11.1 Strive Pharmaceuticals Company Information
11.11.2 Strive Pharmaceuticals Dextromethorphan Product Offered
11.11.3 Strive Pharmaceuticals Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Strive Pharmaceuticals Main Business Overview
11.11.5 Strive Pharmaceuticals Latest Developments
11.12 Cellix Bio
11.12.1 Cellix Bio Company Information
11.12.2 Cellix Bio Dextromethorphan Product Offered
11.12.3 Cellix Bio Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Cellix Bio Main Business Overview
11.12.5 Cellix Bio Latest Developments
11.13 Stada Arzneimittel
11.13.1 Stada Arzneimittel Company Information
11.13.2 Stada Arzneimittel Dextromethorphan Product Offered
11.13.3 Stada Arzneimittel Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Stada Arzneimittel Main Business Overview
11.13.5 Stada Arzneimittel Latest Developments
11.14 Yabo Pharmaceutical
11.14.1 Yabo Pharmaceutical Company Information
11.14.2 Yabo Pharmaceutical Dextromethorphan Product Offered
11.14.3 Yabo Pharmaceutical Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Yabo Pharmaceutical Main Business Overview
11.14.5 Yabo Pharmaceutical Latest Developments
11.15 Zhuhai Tianda Pharma
11.15.1 Zhuhai Tianda Pharma Company Information
11.15.2 Zhuhai Tianda Pharma Dextromethorphan Product Offered
11.15.3 Zhuhai Tianda Pharma Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Zhuhai Tianda Pharma Main Business Overview
11.15.5 Zhuhai Tianda Pharma Latest Developments
11.16 Sichuan Shenghe Pharmaceutical
11.16.1 Sichuan Shenghe Pharmaceutical Company Information
11.16.2 Sichuan Shenghe Pharmaceutical Dextromethorphan Product Offered
11.16.3 Sichuan Shenghe Pharmaceutical Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Sichuan Shenghe Pharmaceutical Main Business Overview
11.16.5 Sichuan Shenghe Pharmaceutical Latest Developments
11.17 Zhejiang Kangde Pharmaceutical Group
11.17.1 Zhejiang Kangde Pharmaceutical Group Company Information
11.17.2 Zhejiang Kangde Pharmaceutical Group Dextromethorphan Product Offered
11.17.3 Zhejiang Kangde Pharmaceutical Group Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Zhejiang Kangde Pharmaceutical Group Main Business Overview
11.17.5 Zhejiang Kangde Pharmaceutical Group Latest Developments
11.18 Zhejiang Anbao Pharmaceutical
11.18.1 Zhejiang Anbao Pharmaceutical Company Information
11.18.2 Zhejiang Anbao Pharmaceutical Dextromethorphan Product Offered
11.18.3 Zhejiang Anbao Pharmaceutical Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Zhejiang Anbao Pharmaceutical Main Business Overview
11.18.5 Zhejiang Anbao Pharmaceutical Latest Developments
11.19 Jiangsu Zhongtian Pharmaceutical
11.19.1 Jiangsu Zhongtian Pharmaceutical Company Information
11.19.2 Jiangsu Zhongtian Pharmaceutical Dextromethorphan Product Offered
11.19.3 Jiangsu Zhongtian Pharmaceutical Dextromethorphan Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Jiangsu Zhongtian Pharmaceutical Main Business Overview
11.19.5 Jiangsu Zhongtian Pharmaceutical Latest Developments
12 Research Findings and Conclusion